Chemours Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chemours Co (CC)
Chemours Co stock price live, this page displays NYSE CC stock exchange data. View the CC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chemours Co real time stock price chart below.
What Is the Chemours Co Stock Price Today?
The Chemours Co stock price today is 13.28.
What Is the Stock Symbol for Chemours Co?
The stock symbol for Chemours Co is "CC."
What Stock Exchange Does Chemours Co Trade On?
Chemours Co is listed and trades on the NYSE stock exchange.
Is Chemours Co a Good Stock to Buy?
Determining whether Chemours Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CC quote. (ISIN: US1638511089)
What Is the Chemours Co Stock Price Today?
The Chemours Co stock price today is 13.28.
What Is the Stock Symbol for Chemours Co?
The stock symbol for Chemours Co is "CC."
What Stock Exchange Does Chemours Co Trade On?
Chemours Co is listed and trades on the NYSE stock exchange.
Is Chemours Co a Good Stock to Buy?
Determining whether Chemours Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CC quote. (ISIN: US1638511089)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.79
13.47
52 wk Range
10.44
28.67
CC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.7913.47
52 wk Range
10.4428.67
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
16.10
Upside
+21.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Chemours stock up 2% on outlook despite Q3 miss- Investing.com
Chemours Co receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Chemours Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Chemours Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Chemours Co receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
2 Buy
8 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 16.10
(+21.23% Upside)
Chemours Co SWOT Analysis
Strategic Resilience | Chemours demonstrates adaptability amidst industry challenges, implementing cost-saving measures and diversifying its product portfolio to maintain competitive edge |
Regulatory Catalysts | Explore how environmental regulations are driving demand for Chemours' eco-friendly refrigerants and cooling solutions, particularly in the TSS segment |
Financial Outlook | Analysts project EBITDA of $825-975 million for FY 2025, with price targets ranging from $19 to $27, reflecting cautious optimism about growth potential |
Innovation Frontie | Delve into Chemours' data center cooling technology, which could capture a substantial share of a $3 billion market and significantly boost future earnings |
Chemours Co Earnings Call Summary for Q3/2026
- Chemours Q3 earnings missed estimates at $0.21/share vs. $0.27 expected, but adjusted EBITDA of $200M hit top of guidance range.
- Revenue rose 3% YoY to $1.5B on 10% Titanium Technologies pricing gains and 26% APM Performance Solutions growth driven by AI/semiconductor demand.
- Company maintained 2026 guidance of 2% sales growth and $775M-$800M EBITDA; expects earnings growth in 2027 despite macro uncertainty.
- Net leverage expected below 4.2x by year-end 2026 after €50M debt prepayment; free cash flow conversion forecast at 15%-20% for full year.
- Launched Faizeon branded liquid cooling fluids for AI data centers; AI/semiconductor exposure now represents 10% of TT and APM sales concentration.
Last Updated: 2026-11-03, 08:54 a/m
Read Full TranscriptEarnings
Latest Release
Nov 02, 2026
EPS / Forecast
0.21 / 0.27
Revenue / Forecast
1.5B / 1.53B
Compare CC to Peers and Sector
Metrics to compare | CC | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipCCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.0x | 14.3x | 3.8x | |
PEG Ratio | −0.22 | −0.13 | 0.00 | |
Price/Book | 12.9x | 0.8x | 1.6x | |
Price / LTM Sales | 0.3x | 0.4x | 1.1x | |
Upside (Analyst Target) | 20.5% | 50.4% | 49.1% | |
Fair Value Upside | Unlock | −0.2% | 5.2% | Unlock |
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Chemours Co (CC) Stock Price Today?
The Chemours Co stock price today is 13.28 USD.
What Stock Exchange Does Chemours Co Trade On?
Chemours Co is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Chemours Co?
The stock symbol for Chemours Co is "CC."
Does Chemours Co Pay Dividends? What’s The Current Dividend Yield?
The Chemours Co dividend yield is 2.7%%.
What Is the Chemours Co Market Cap?
As of today, Chemours Co market cap is 1.92B USD.
What Is Chemours Co's Earnings Per Share (TTM)?
The Chemours Co EPS (TTM) is -1.02.
When Is the Next Chemours Co Earnings Date?
Chemours Co will release its next earnings report on Feb 11, 2027.
From a Technical Analysis Perspective, Is CC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Chemours Co Stock Split?
Chemours Co has split 0 times.
How Many Employees Does Chemours Co Have?
Chemours Co has 5700 employees.
What is the current trading status of Chemours Co (CC)?
As of Nov 09, 2026, Chemours Co (CC) is trading at a price of 13.28 USD, with a previous close of 12.75 USD. The stock has fluctuated within a day range of 12.79 USD to 13.47 USD, while its 52-week range spans from 10.44 USD to 28.67 USD.
What Is Chemours Co (CC) Price Target According to Analysts?
The average 12-month price target for Chemours Co is 16.10 USD, with a high estimate of 18 USD and a low estimate of 14 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +21.23% Upside potential.
What Is the CC Premarket Price?
CC's last pre-market stock price is 12.95 USD. The pre-market share volume is 990.00, and the stock has decreased by 0.20, or 1.57%.
What Is the CC After Hours Price?
CC's last after hours stock price is 13.35 USD, the stock has decreased by 0.07, or 0.53%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.